The Centers for Medicare and Medicaid Services announced on Wednesday that 27 drugs had large price hikes like the rheumatoid-arthritis treatment Humira from AbbVie. These drug companies will all face price-increase penalties from the government. The money taken back will go into the hospital Medicare Trust Fund, which is facing a shortfall.